Category Archives: Public Policy

Latest From Public Policy

BIO IP News Weekly for June 19, 2009

This week I include a Nature Biotechnology article on scientific communications, a BBC article on river blindness, and a Heritage Foundation essay on patents.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags:

White House Picks Kappos to Lead USPTO

Yesterday the White House nominated David J. Kappos for Under Secretary of Commerce for IP and as the Director of the United States Patent and Trademark Office (USPTO). BIO released its commendation on the nomination today.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO to USA Today: Patents Promote Innovation

Public debate over access to, and use of, genetic technology is a good thing. It requires the consideration of many factors, including coverage and cost, concerns over genetic discrimination and myriad regulatory issues.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Patent Docs: Falsehoods, Distortions and Outright Lies in the Gene Patenting Debate

Patent Docs blog reviewed the most repeated criticisms of the patenting of genetic materials, providing a critical hand to assist non-technical observers of the debate currently swirling around in legal, scientific, and academic circles.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Patenting Genes: NPR Talks IP with BIO

Today, June 4, 2009 at 1:00 PM ET DC’s WAMU Radio Station (88.5 FM) or at  http://wamu.org/programs/kn/09/06/04.php#26424 The genetic material in our cells make us who we are. But since 1982, the U.S. Patent Office has issued tens of thousands of patents to private companies for gene-related products. The biotechnology industry says these patents are necessary to spur innovation. Opponents say they actually stifle science. We examine the intersection of cutting-edge genetic research and intellectual Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: